GE HealthCare (Nasdaq: GEHC) announced a $138 million investment to expand its contrast media fill/finish manufacturing site in Cork, Ireland. The company plans to expand with a new, state-of-the-art facility on the existing grounds of the Carrigtohill, Cork, site. It anticipates 25 million more patient doses per year of contrast media by the end of…
GE HealthCare to fully own Nihon Medi-Physics
GE HealthCare (Nasdaq:GEHC) announced today that it will acquire the remaining 50% stake in Nihon Medi-Physics, enabling it to fully own the Japanese radiopharmaceutical company. The purchase from Sumitomo Chemical is expected to close in early 2025, subject to regulatory approvals. Financial terms of the deal were not disclosed. GE HealthCare has already owned a…
GE HealthCare investing $80M in contrast media ingredients plant in Norway
GE HealthCare today announced it is investing $80 million to expand contrast media production capacity in Norway. The investment will go toward increasing manufacturing capacity by 30% at its active pharmaceutical ingredients site in Lindesnes, Norway. As a result, the investment will create around 100 new jobs. GE HealthCare officials have committed to addressing the…